Genetic Neuropathology of Schizophrenia: New Approaches to an Old Question and New Uses for Postmortem Human Brains
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Human postmortem brain studies are critical for elucidating the pathophysiology and etiology of schizophrenia and other major mental illnesses. The traditional approach compares patients and controls, but is potentially confounded by a number of artifacts including medication, substance misuse and other secondary effects of illness. Now, genetic advances make possible a novel approach that focuses on how allelic variation in risk-associated genes impacts on expression and function of transcripts and proteins. These questions can be addressed in normal brain, overcoming to some extent the confounding effects of studying brains from subjects with schizophrenia; equally, extension of the studies to include cases also has advantages. Conceptually, the approach may be seen as the neuropathologic counterpart of genetic neuroimaging, representing a potentially powerful intermediate phenotype. For several schizophrenia susceptibility genes, the data show that risk-associated polymorphisms do affect gene expression or the function of the encoded protein; in some instances expression of downstream or interacting partners of the gene are also altered. A further striking finding is that the implicated transcripts often appear to be enriched in, or specific to, human brain. Some also show enhanced expression in fetal brain. These considerations give a unique importance to postmortem human brain tissue in elucidating the genetic mechanisms underlying schizophrenia, and probably other neurodevelopmental disorders too. Studies of this kind can provide clues as to the biologic mechanisms of genetic association, especially when carried out in conjunction with experimental studies. Moreover, the data, interpreted judiciously, can strengthen the plausibility of the association itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Self-citationThe neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Self-citationChen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Self-citationIntermediate phenotypes and genetic mechanisms of psychiatric disorders
Meyer-Lindenberg, A., & Weinberger, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1993 · Cited by 1,216
Self-citationNeuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030 · cited 1×
“Neuregulin 1 (NRG1) has been repeatedly associated genetically with schizophrenia, yet its large size, multiple isoforms, and the fact that the associated SNPs are virtually all noncoding, has hindered biologic explanations for the association (47, 48).”
BackgroundAbundant quantitative trait loci exist for DNA methylation and gene expression in human brain
Gibbs, J. R., van der Brug, M. P., Hernandez, D. G., Traynor, B. J., Nalls, M. A., Lai, S.-L., Arepalli, S., Dillman, A., Rafferty, I. P., Troncoso, J., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000952 · Cited by 769 · cited 1×
“And, although we have focused mainly on analysis of candidate genes, effects of allelic variation on gene expression in postmortem human brain also lend themselves well to the agnostic approaches of microarray studies, with several studies already demonstrating relationships between genome-wide SNP analyses and expres…”
BackgroundA survey of genetic human cortical gene expression
Myers, A. J., Gibbs, J. R., Webster, J. A., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., Leung, D., Bryden, L., Nath, P., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.16 · Cited by 479 · cited 1×
“And, although we have focused mainly on analysis of candidate genes, effects of allelic variation on gene expression in postmortem human brain also lend themselves well to the agnostic approaches of microarray studies, with several studies already demonstrating relationships between genome-wide SNP analyses and expres…”
BackgroundNeural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis
Mier, D., Kirsch, P., & Meyer-Lindenberg, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.36 · Cited by 464 · cited 1×
“The genotype effect on COMT activity (about a 30% difference between homozygotes) is seen in human postmortem brain (9), providing biologic plausibility to the multitude of studies, showing that this SNP impacts upon a range of cognitive, neuroimaging and other phenotypes (7,10, 11).”
BackgroundDisease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · cited 6×
“As a final illustration, other microarray studies have identified two oligodendrocyte transcripts, CNP and OLIG2, decreased in dorsolateral PFC in schizophrenia (35–37, but see 38), and with some subsequent evidence for genetic Biol Psychiatry.”
BackgroundInfluentialMidbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype
Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D. R., & Berman, K. F. (2005) · Nature Neuroscience · doi:10.1038/nn1438 · Cited by 428 · cited 1×
“genotype also affected tyrosine hydroxylase expression in the midbrain, providing a mechanistic link between cortical metabolism of dopamine and this key index of presynaptic dopamine function, complemented subsequently by findings in a functional neuroimaging study (13).”
ResultSelf-citationAssociation and linkage analyses of RGS4 polymorphisms in schizophrenia
Chowdari, K. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1373 · Cited by 368
Catechol- O -Methyltransferase Genotype and Dopamine Regulation in the Human Brain
Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02008.2003 · Cited by 325
Self-citationSchizophrenia: More dopamine, more D 2 receptors
Seeman, P., & Kapur, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7673 · Cited by 279 · cited 10×
“These demonstrated increased DRD2 in striatum and other brain regions, as shown by meta-analysis (22), with some studies also finding elevated DRD2 mRNA (23, 24).”
BackgroundInfluentialTunbridge, E., Weickert, C., Kleinman, J., Herman, M., Chen, J., Kolachana, B., Harrison, P., & Weinberger, D. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl032 · Cited by 197
Self-citationDISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms
Nakata, K., Lipska, B. K., Hyde, T. M., Ye, T., Newburn, E. N., Morita, Y., Vakkalanka, R., Barenboim, M., Sei, Y., Weinberger, D. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903413106 · Cited by 182
Self-citationExpression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs
Lipska, B. K., Peters, T., Hyde, T. M., Halim, N., Horowitz, C., Mitkus, S., Weickert, C. S., Matsumoto, M., Sawa, A., Straub, R. E., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl040 · Cited by 168 · cited 2×
“For the strong schizophrenia candidate gene, DISC1, an initial study did not find that DISC1 risk alleles correlated with expression of any of its known transcripts in either PFC or hippocampus (52), but – like GRM3 and KCNH2 - further study using RACE and transcript cloning then identified multiple novel DISC1 trunca…”
BackgroundSelf-citationFine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia
Chen, P.-L., Avramopoulos, D., Lasseter, V. K., McGrath, J. A., Fallin, M. D., Liang, K.-Y., Nestadt, G., Feng, N., Steel, G., Cutting, A. S., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.12.005 · Cited by 83 · cited 1×
“As a final example, postmortem brains have also been integral to identification of a probable mechanistic basis for the association of polymorphisms in intron 1 of neuregulin 3 (NRG3), another member of the neuregulin gene family and the specific ERBB4 ligand, with risk for, and delusional severity in, schizophrenia (…”
Background
Cited by
Neurodevelopmental model of schizophrenia: update 2012
Rapoport, J. L., Giedd, J. N., & Gogtay, N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.23 · Cited by 790
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 543
Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex
Jaffe, A. E., Gao, Y., Deep-Soboslay, A., Tao, R., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2016) · Nature Neuroscience · doi:10.1038/nn.4181 · Cited by 511
“Furthermore, DNAm levels may be a more proximal read out of genetic variation than gene expression levels 42 – here we identified that 62/104 (59.6”
InfluentialSelf-citationGenetic insights into the neurodevelopmental origins of schizophrenia
Birnbaum, R., & Weinberger, D. R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.125 · Cited by 494
Self-citationDNA methylation signatures in development and aging of the human prefrontal cortex
Numata, S., Ye, T., Hyde, T. M., Guitart-Navarro, X., Tao, R., Wininger, M., Colantuoni, C., Weinberger, D. R., Kleinman, J. E., & Lipska, B. K. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.020 · Cited by 364
“270 The American Journal of Human Genetics 90, 260–272, February associations with DNA methylation are consistent with the possibility that some SNPs associated with increased risk for neuropsychiatric diseases might affect gene expression through DNA methylation, in addition to their direct effects on mRNA expression…”
BackgroundSelf-citation
Metadata
- Authors
- Kleinman, J. E., Law, A. J., Lipska, B. K., Hyde, T. M., Ellis, J. K., Harrison, P. J., & Weinberger, D. R.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 69
- Issue
- 2
- Pages
- 140-145
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2074270215
- Cited by
- 90
- References
- 19
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.